BamSEC and AlphaSense Join Forces
Learn More

GreenLight Biosciences Inc

Formerly NASDAQ: GRNA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10
from 10-K 43 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is Not Material and of the Type That the Reigstrant Treats as Private or Confidential. [***] Indicates That Information Has Been Omitted. Collaboration and License Agreement
12/34/56
EX-10
from 10-K 76 pages Docusign Envelope Id: 3d9421bf-E23b-4f57-8c3d-Fc854d1c296d Lease Agreement Rentable Area of Premises: 59,000 Sq. Ft. Rentable Area of Project: 59,000 Sq. Ft. Tenant’s Share of Operating Expenses: 100% Security Deposit: $958,750.00 Target Commencement Date: May 1, 2022 Rent Adjustment Percentage: 3% Address for Rent Payment: Landlord’s Notice Address: Po Box 975383 26 North Euclid Avenue Dallas, Tx 75397-5383 Pasadena, Ca 91101 Attention: Corporate Secretary Tenant’s Notice Address: 200 Boston Avenue Medford, Ma 02155 Attention: Legal Department
12/34/56
EX-10
from 10-K 13 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is Not Material and of the Type That the Reigstrant Treats as Private or Confidential. [***] Indicates That Information Has Been Omitted
12/34/56
EX-10.36
from S-1 5 pages Third Amendment to Lease
12/34/56
EX-10.35
from S-1 3 pages First Amendment to Lease
12/34/56
EX-10.34
from S-1 54 pages Lease Agreement
12/34/56
EX-10.1
from 8-K 20 pages Subscription Agreement August 11, 2022
12/34/56
EX-10.32
from POS AM 43 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is Not Material and of the Type That the Registrant Treats as Private or Confidential. [***] Indicates That Information Has Been Omitted. License Agreement Between Serum Institute of India Private Limited and GreenLight Biosciences, Inc
12/34/56
EX-10.38
from S-4/A 3 pages Greenlight Biosciences, Inc. Environmental Impact Acquisition Corp
12/34/56
EX-10.37
from S-4/A 13 pages Convertible Investment Instrument Agreement
12/34/56
EX-10.36
from S-4/A 4 pages Convertible Instrument
12/34/56
EX-10.17
from S-4/A 19 pages Greenlight Biosciences, Inc. Indemnification Agreement
12/34/56
EX-10.1
from 8-K 3 pages [Form of Letter Agreement] Greenlight Biosciences, Inc. Environmental Impact Acquisition Corp
12/34/56
EX-10.34
from S-4/A 9 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is Not Material and of the Type That the Registrant Treats as Private or Confidential. [***] Indicates That Information Has Been Omitted. Samsung Biologics Co., Ltd. Product Specific Agreement – Clinical Product Drug Substance
12/34/56
EX-10.10
from S-4/A 3 pages Restricted Stock Unit Award Agreement Under the Greenlight Biosciences, Inc. 2021 Equity and Incentive Plan
12/34/56
EX-10.9
from S-4/A 4 pages Restricted Stock Award Agreement Under the Greenlight Biosciences, Inc. 2021 Equity and Incentive Plan
12/34/56
EX-10.8
from S-4/A 6 pages Incentive Stock Option Agreement Under the Greenlight Biosciences, Inc. 2021 Equity and Incentive Plan
12/34/56
EX-10.7
from S-4/A 5 pages Nonstatutory Stock Option Agreement Under the Greenlight Biosciences, Inc. 2021 Equity and Incentive Plan
12/34/56
EX-10.34
from S-4/A 9 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is Not Material and of the Type That the Registrant Treats as Private or Confidential. [***] Indicates That Information Has Been Omitted. Samsung Biologics Co., Ltd. Product Specific Agreement – Clinical Product Drug Substance
12/34/56
EX-10.33
from S-4/A 34 pages Certain Identified Information Has Been Omitted From This Exhibit Because It Is Not Material and of the Type That the Registrant Treats as Private or Confidential. [***] Indicates That Information Has Been Omitted. Master Services Agreement Between Samsung Biologics Co., Ltd. and Greenlight Biosciences, Inc. 1
12/34/56